StemCells Inc (NASDAQ:STEM)

0.6101
Delayed Data
As of Apr 24
 -0.2099 / -25.60%
Today’s Change
0.54
Today|||52-Week Range
2.43
-35.03%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$42.3M

Company Description

StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA.

Contact Information

StemCells, Inc.
7707 Gateway Boulevard
Newark California 94560
P:(510) 456-4000
Investor Relations:

Employees

Shareholders

Mutual fund holders3.49%
Individual stakeholders2.61%
Other institutional13.81%

Top Executives

Martin M. McGlynnChief Executive Officer & Director
Ian John MasseyPresident & Chief Operating Officer
Gregory T. SchiffmanChief Financial Officer & Executive Vice President
Stephen HuhnChief Medical Officer & VP-CNS Clinical Research
Ann TsukamotoEVP-Scientific & Strategic Alliances

To view my watchlist

Not a member yet?

Sign up now for a free account